Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1

Shinji Sato, Jiqing Xu, Satoshi Okuyama, Lindsey B. Martinez, Shannon M. Walsh, Michael T. Jacobsen, Russell J. Swan, Joshua D. Schlautman, Pawel S Ciborowski, Tsuneya Ikezu

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Tau-tubulin kinase-1 (TTBK1) is involved in phosphorylation of tau protein at specific Serine/Threonine residues found in paired helical filaments, suggesting its role in tauopathy pathogenesis. We found that TTBK1 levels were upregulated in brains of human Alzheimer' disease (AD) patients compared with age-matched non-AD controls. To understand the effects of TTBK1 activation in vivo,we developed transgenic mice harboring human full-length TTBK1 genomic DNA (TTBK1-Tg). Transgenic TTBK1 is highly expressed in subiculum and cortical pyramidal layers, and induces phosphorylated neurofilament aggregation. TTBK1-Tg mice show significant age-dependent memory impairment as determined by radial arm water maze test, which is associated with enhancement of tau and neurofilament phosphorylation, increased levels of p25 and p35, both activators of cyclin-dependent protein kinase 5 (CDK5), enhanced calpain I activity, and reduced levels of hippocampal NMDA receptor types 2B (NR2B) and D. Enhanced CDK5/p35 complex formation is strongly correlated with dissociation of F-actin from p35, suggesting the inhibitory mechanism of CDK5/p35 complex formation by F-actin. Expression of recombinant TTBK1 in primary mouse cortical neurons significantly downregulated NR2B in a CDK5- and calpain-dependent manner. These data suggest that TTBK1 in AD brain may be one of the underlying mechanisms inducing CDK5 and calpain activation, NR2B downregulation, and subsequent memory dysfunction.

Original languageEnglish (US)
Pages (from-to)14511-14521
Number of pages11
JournalJournal of Neuroscience
Volume28
Issue number53
DOIs
StatePublished - Dec 31 2008

Fingerprint

Cyclin-Dependent Kinase 5
Cyclin-Dependent Kinases
N-Methyl-D-Aspartate Receptors
Transgenic Mice
Down-Regulation
Calpain
Intermediate Filaments
Actins
Alzheimer Disease
Phosphorylation
Tauopathies
Spatial Learning
tau-tubulin kinase
tau Proteins
Brain
Threonine
Serine
Hippocampus

Keywords

  • Alzheimer's disease
  • Memory
  • NMDA receptor
  • Neuropathology
  • Phosphorylation
  • Protein kinase
  • Transgenic

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. / Sato, Shinji; Xu, Jiqing; Okuyama, Satoshi; Martinez, Lindsey B.; Walsh, Shannon M.; Jacobsen, Michael T.; Swan, Russell J.; Schlautman, Joshua D.; Ciborowski, Pawel S; Ikezu, Tsuneya.

In: Journal of Neuroscience, Vol. 28, No. 53, 31.12.2008, p. 14511-14521.

Research output: Contribution to journalArticle

Sato, Shinji ; Xu, Jiqing ; Okuyama, Satoshi ; Martinez, Lindsey B. ; Walsh, Shannon M. ; Jacobsen, Michael T. ; Swan, Russell J. ; Schlautman, Joshua D. ; Ciborowski, Pawel S ; Ikezu, Tsuneya. / Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. In: Journal of Neuroscience. 2008 ; Vol. 28, No. 53. pp. 14511-14521.
@article{5136fa9dd43a45948c16c36c26f909e2,
title = "Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1",
abstract = "Tau-tubulin kinase-1 (TTBK1) is involved in phosphorylation of tau protein at specific Serine/Threonine residues found in paired helical filaments, suggesting its role in tauopathy pathogenesis. We found that TTBK1 levels were upregulated in brains of human Alzheimer' disease (AD) patients compared with age-matched non-AD controls. To understand the effects of TTBK1 activation in vivo,we developed transgenic mice harboring human full-length TTBK1 genomic DNA (TTBK1-Tg). Transgenic TTBK1 is highly expressed in subiculum and cortical pyramidal layers, and induces phosphorylated neurofilament aggregation. TTBK1-Tg mice show significant age-dependent memory impairment as determined by radial arm water maze test, which is associated with enhancement of tau and neurofilament phosphorylation, increased levels of p25 and p35, both activators of cyclin-dependent protein kinase 5 (CDK5), enhanced calpain I activity, and reduced levels of hippocampal NMDA receptor types 2B (NR2B) and D. Enhanced CDK5/p35 complex formation is strongly correlated with dissociation of F-actin from p35, suggesting the inhibitory mechanism of CDK5/p35 complex formation by F-actin. Expression of recombinant TTBK1 in primary mouse cortical neurons significantly downregulated NR2B in a CDK5- and calpain-dependent manner. These data suggest that TTBK1 in AD brain may be one of the underlying mechanisms inducing CDK5 and calpain activation, NR2B downregulation, and subsequent memory dysfunction.",
keywords = "Alzheimer's disease, Memory, NMDA receptor, Neuropathology, Phosphorylation, Protein kinase, Transgenic",
author = "Shinji Sato and Jiqing Xu and Satoshi Okuyama and Martinez, {Lindsey B.} and Walsh, {Shannon M.} and Jacobsen, {Michael T.} and Swan, {Russell J.} and Schlautman, {Joshua D.} and Ciborowski, {Pawel S} and Tsuneya Ikezu",
year = "2008",
month = "12",
day = "31",
doi = "10.1523/JNEUROSCI.3417-08.2008",
language = "English (US)",
volume = "28",
pages = "14511--14521",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "53",

}

TY - JOUR

T1 - Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1

AU - Sato, Shinji

AU - Xu, Jiqing

AU - Okuyama, Satoshi

AU - Martinez, Lindsey B.

AU - Walsh, Shannon M.

AU - Jacobsen, Michael T.

AU - Swan, Russell J.

AU - Schlautman, Joshua D.

AU - Ciborowski, Pawel S

AU - Ikezu, Tsuneya

PY - 2008/12/31

Y1 - 2008/12/31

N2 - Tau-tubulin kinase-1 (TTBK1) is involved in phosphorylation of tau protein at specific Serine/Threonine residues found in paired helical filaments, suggesting its role in tauopathy pathogenesis. We found that TTBK1 levels were upregulated in brains of human Alzheimer' disease (AD) patients compared with age-matched non-AD controls. To understand the effects of TTBK1 activation in vivo,we developed transgenic mice harboring human full-length TTBK1 genomic DNA (TTBK1-Tg). Transgenic TTBK1 is highly expressed in subiculum and cortical pyramidal layers, and induces phosphorylated neurofilament aggregation. TTBK1-Tg mice show significant age-dependent memory impairment as determined by radial arm water maze test, which is associated with enhancement of tau and neurofilament phosphorylation, increased levels of p25 and p35, both activators of cyclin-dependent protein kinase 5 (CDK5), enhanced calpain I activity, and reduced levels of hippocampal NMDA receptor types 2B (NR2B) and D. Enhanced CDK5/p35 complex formation is strongly correlated with dissociation of F-actin from p35, suggesting the inhibitory mechanism of CDK5/p35 complex formation by F-actin. Expression of recombinant TTBK1 in primary mouse cortical neurons significantly downregulated NR2B in a CDK5- and calpain-dependent manner. These data suggest that TTBK1 in AD brain may be one of the underlying mechanisms inducing CDK5 and calpain activation, NR2B downregulation, and subsequent memory dysfunction.

AB - Tau-tubulin kinase-1 (TTBK1) is involved in phosphorylation of tau protein at specific Serine/Threonine residues found in paired helical filaments, suggesting its role in tauopathy pathogenesis. We found that TTBK1 levels were upregulated in brains of human Alzheimer' disease (AD) patients compared with age-matched non-AD controls. To understand the effects of TTBK1 activation in vivo,we developed transgenic mice harboring human full-length TTBK1 genomic DNA (TTBK1-Tg). Transgenic TTBK1 is highly expressed in subiculum and cortical pyramidal layers, and induces phosphorylated neurofilament aggregation. TTBK1-Tg mice show significant age-dependent memory impairment as determined by radial arm water maze test, which is associated with enhancement of tau and neurofilament phosphorylation, increased levels of p25 and p35, both activators of cyclin-dependent protein kinase 5 (CDK5), enhanced calpain I activity, and reduced levels of hippocampal NMDA receptor types 2B (NR2B) and D. Enhanced CDK5/p35 complex formation is strongly correlated with dissociation of F-actin from p35, suggesting the inhibitory mechanism of CDK5/p35 complex formation by F-actin. Expression of recombinant TTBK1 in primary mouse cortical neurons significantly downregulated NR2B in a CDK5- and calpain-dependent manner. These data suggest that TTBK1 in AD brain may be one of the underlying mechanisms inducing CDK5 and calpain activation, NR2B downregulation, and subsequent memory dysfunction.

KW - Alzheimer's disease

KW - Memory

KW - NMDA receptor

KW - Neuropathology

KW - Phosphorylation

KW - Protein kinase

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=58149379158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149379158&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3417-08.2008

DO - 10.1523/JNEUROSCI.3417-08.2008

M3 - Article

VL - 28

SP - 14511

EP - 14521

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 53

ER -